ASSESSMENT OF SERUM LIPID PROFILE IN HYPERTENSIVE PATIENTS: A CASE-CONTROL STUDY

Main Article Content

Sushma Reddy V
Hari Prasad TV
Surendra B V

Abstract

Background: Hypertension and dyslipidemia are strongly associated with each other, and they are the most common risk factors for the development of the cardiovascular disease.


Aim: Compare the serum lipid profile values among hypertensive patients and non-hypertensive individuals.


Method: 30 patients with Hypertension and 30 age-matched non-hypertensive controls were included in the study. From the serum, total cholesterol levels were estimated by enzymatic (CHOD-PAP) colorimetric method, triglyceride by enzymatic (GPO-PAP) method, HDL-cholesterol and LDL-cholesterol were estimated using precipitant and Friedewald formula, by using commercially available reagent kits. Lipid profiles were compared with controls.


Results: The mean values of total cholesterol were significantly more in Hypertensives-202.93 ± 28.44 and normotensives-178.76 ± 37.21, P<0.006. The mean values of triglycerides were significantly more in Hypertensives-139.8 ± 18.72 and normotensives-125.8± 12.34, P<0.001. The mean values of LDL-Cholesterol were significantly more in Hypertensives-141.63 ± 11.59 and normotensives-127.83 ± 14.65, P<0.0001.


Conclusions: As Dyslipidemia is associated with Hypertension, serum lipid profile may be useful in the identification of patients at risk of Hypertension. Hypertensive patients need the measurement of blood pressure and lipid profile at regular intervals to prevent Cardiovascular diseases.


Keywords: Cholesterol; Cardiovascular Diseases; Hypertension; Triglycerides; Dyslipidemia.

Keywords
  • Cholesterol; Cardiovascular Diseases; Hypertension; Triglycerides; Dyslipidemia.

Article Details

How to Cite
V, S., TV, H., & V, S. (2020). ASSESSMENT OF SERUM LIPID PROFILE IN HYPERTENSIVE PATIENTS: A CASE-CONTROL STUDY. International Journal of Clinical and Biomedical Research, 6(1), 21-24. https://doi.org/10.31878/ijcbr.2019.61.06

References

He J, Whelton PK. Epidemiology and prevention of hypertension. Med Clin North Am. 1997;81:1077–97

Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA. 2007;297(3):286–94

Kumar A, Nagtilak S, Sivakanesan R, Gunasekera S. Cardio-vascular risk factors in elderly Normolipidimic acute myocardial infarction patients – A case-controlled study from India. Southeast Asian J Trop Med Public Health. 2009;40(3):581–92

Wannarinthee SC, Shaper AG, Durington PN, Perry M. Metabolic Syndrome. J. Human Hypertension, 1998;12(2): 1059-64.

Lipid Research Clinic Program. The lipid research clinic coronary primary prevention trial results II. J.Am. Med. Assoc. 1984;251:364-74.

Fogelman A, I. Schechter J. Seager. Alteration of low density lipoproteins leads to cholesterylester accumulation in human monocyte macrophages. Proc. Natl. Acad. Sci., USA, 1980;77:2214-8

Palinski W, Rosenfeld M, Yla-Herttuala S. Low density lipoprotein undergoes oxidative modification in vivo. Proc.Natl. Acad. Sci., USA. 1989;86:1372-6.

Allain CC, Poon IS, Chan CHG, Richmond W, Fu PC. Enzymatic determination of serum total cholesterol.Clin. Chem. 1974; 20: 470-1

Jacobs NJ, VanDenmark PJ. Enzymatic determination of serum triglyceride.ch. Biochem. Biophys. 1960;88:250-5.

Gordon T and Gordon M, Enzymatic method to determine the serum HDL-cholesterol. Am. J. Med. 1977; 62: 707-8

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of LDL-cholesterol. Clin. Chem. 1972;18 (6): 499-515

Third Report of the National Cholesterol Education Program (NCEP), “Expert panel on detection, evaluation, and treat- ment of high blood cholesterol in adults (Adult Treatment Panel III) final report,” Circulation, 2002; 106: 3143–421.

Sabri S, Bener A, Eapen V, Abu Zeid MS, Al- Mazrouei AM, Singh J. Some risk factors for hypertension in the United Arab Emirates. East Mediterr Health J. 2004; 10(4-5):610-9

Yin R, Chen Y, Pan S, He F, Liu T, Yang D, et al. Comparison of lipid levels, hyperlipidemia prevalence and its risk factors between Guangxi Hei Yi Zhuang and Han populations. Arch Med Res. 2006;37(6):787-93.

Shahadat H, Maliha R, Iqbal A, Suhrab A. Study of serum lipid profile in essential hypertensive patients. Mym Med J. 1999;8(1):22–5.

Adedeji OO, Onitiri AC. Lipids in Nigerian hypertensives. Afr J Med Sci. 1990;19:281–4.

Saha MS, Saha NK, Shaha RK. Serum lipid profile of hypertensive patients in the northern region of Bangladesh. J Biosci. 2006;14:93

Oparil S, Zaman MA, Calhoun DA. Pathogenesis of hypertension. Ann Intern Med. 2003;139:761-76.

Selwyn AP, Kinlay S, Libby P, Ganz P. Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease. Circulation. 1997;95:5-7.

Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2:997-1000.

Schaeffner ES, Kurth T, Curhan GC, Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol. 2003;14:2084- 91.